Monoclonal Anti-Insulin-Like Growth Factor Binding Protein-1 antibody produced in mouse

REF : I2032-500UG
Marca : Sigma-Aldrich
Descrição :Monoclonal Anti-Insulin-Like Growth Factor Binding Protein-1 antibody produced in mouse clone 33627.11, purified immunoglobulin, lyophilized powder
Clique para mais informações
Categoria :
Descrição detalhada : The effects of insulin-like growth factors (IGF) are modulated by a family of insulin-like growth factor binding proteins 1-6. (IGFBPs -1-6). IGFBP-1 is secreted as an endocrine factor by liver, kidneys, decidua and in human amniotic fluid, but has the ability to signal in autocrine and paracrine fashion. Post-translational modifications such as ubiquitination, glycosylation and phosphorylation alter the activity of IGFBPs. Phosphorylation of IGFBP-1 is mainly mediated by Casein kinase I and II and cAMP-dependent protein kinases. IGFBP-1 alters the bioavailability of IGF in the serum by binding and sequestration so that a regulated amount id available to act on the target cells. The functions of IGFBP-1 are most important in the physiology of female reproductive system in mammals, for growth and development of the developing fetus Monoclonal Anti-Human Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) recognizes recombinant human IGFBP-1. No cross-reactivity is seen with recombinant human IGFBP-2, IGFBP-3, and IGFBP-4.
Sinónimos : Anti-IGFBP-1
Armazenamento : -20C
Embalagem : 1X500UG